Transcultural Adaptation and Validation to Spanish of the OSPRO Questionnaires (SpanishOSPRO)

May 16, 2023 updated by: Enrique Lluch Girbés, University of Valencia

Transcultural Adaptation and Validation to Spanish of the Optimal Screening for Prediction of Referral and Outcome (OSPRO) Questionnaires for Review-Of-Systems (OSPRO-ROS) and Yellow-Flags (OSPRO-YF) in Subjects With Musculoskeletal Pain.

Clinical guidelines for managing musculoskeletal pain recommend first, assessing and identifying any signs of severe physical conditions (i.e."red flags") and then, asessing the psychosocial prognostic factors of poor outcomes (i.e."yellow flags"). The Optimal Sreening for Prediction of Referral and Outcome (OSPRO) cohort studies were designed to develop and validate standard assessment tools for Review Of Systems (OSPRO-ROS) and Yellow Flags (OSPRO-YF).

Study Overview

Detailed Description

The objectives of this study were to translate and cross-cultural adapt OSPRO-ROS and OSPRO-YF questionnaires to Spanish and to investigate their psychometric properties for their use in subjects with musculoskeletal pain.To accomplish the objectives proposed, this study was developed in two phases:Phase I: Cross-cultural adaptation process.Phase II: Psychometric properties evaluation.

Study Type

Observational

Enrollment (Anticipated)

200

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

  • Name: MARTA TELLO FONTANET
  • Phone Number: 2025 +34937003608
  • Email: MTello@CST.cat

Study Locations

    • Barcelona
      • Sant Cugat Del Vallès, Barcelona, Spain, 08174
        • Recruiting
        • Hospital Asepeyo Sant Cugat
        • Contact:
        • Contact:
      • Terrassa, Barcelona, Spain, 08227
        • Recruiting
        • Consorci Sanitari de Terrassa
        • Contact:
        • Contact:
          • MARTA TELLO FONTANET
          • Phone Number: 2025 +34937003608
          • Email: MTello@CST.cat

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Probability Sample

Study Population

OSPRO-ROS:

Person between 18 and 75 years of age who goes to the emergency department, presenting acute musculoskeletal pain with primary complaints involving the cervical spine, lumbar spine, shoulder or knee.

OSPRO-YF:

Person between 18 and 75 years of age who goes to the rehabilitation department, presenting chronic musculoskeletal pain with primary complaints involving the cervical spine, lumbar spine, shoulder or knee.

Description

Inclusion Criteria:

OSPRO-ROS:

  1. Were coming to the emergency department on their first visit.
  2. With acute musculoskeletal pain.
  3. Were able to read and comprehed Spanish language.

OSPRO-YF:

  1. Were seeking outpatient physical therapy treatment.
  2. With chronic musculoskeletal pain involving the cervical spine, lumbar spine, shoulder or knee.
  3. Were able to read and comprehend Spanish language.

Exclusion Criteria:

  1. Widespread chronic pain syndrome (e.g. fibromyalgia or irritable bowel syndrome).
  2. Neuropathic pain syndrome (e.g. complex regional pain syndrome or diabetic neuropathy).
  3. Psychiatric history (currently in care of mental health care provider or taking > 2 precription psychiatric medications)
  4. Cancer (currently receiving treatment for active cancer)
  5. Neurological disorder (e.g. stroke, spinal cord injury, or traumatic brain injury).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
OSPRO-ROS: 100 patients presenting musculoskeletal pain
Patients between 18 and 75 years of age with primary complaints involving the cervical spine, lumbar spine, shoulder or knee. Were able to read and comprehend Spanish.
Completion of questionnaires
Other Names:
  • Result of complementary tests
  • OSPRO-ROS retest
OSPRO-YF: 100 patients presenting musculoskeletal pain
Patients between 18 and 75 years of age with primary complaints involving the cervical spine, lumbar spine, shoulder or knee. Were able to read and comprehend Spanish.
Completion of questionnaires
Other Names:
  • Chronic Pain Acceptance Questionnaire (CPAQ)
  • Fear-Avoidance Beliefs Questionnaire (FABQ)
  • Pain Catastrophizing Scale (PCS)
  • Patient Health Questionnaire-9 (PHQ-9)
  • State Trait Anxiety Inventory (STAI)
  • Tampa Scale for Kinesiophobia-11 (TSK-11)
  • OSPRO-YF retest

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient-Reported Outcome Measure (PROM) development: Translation and Cross Cultural Adaptation to the Spanish population of the Optimal Screening for Prediction of Referral and Outcome (OSPRO) questionnaires.
Time Frame: from September 2018 to July 2021

Two native Spanish speakers, health experienced in musculoskeletal pain and knowledge of English, translated into Spanish the Optimal Screening for Prediction of Referral and Outcome-Review of Systems (OSPRO-ROS) questionnaire original (English) and the Optimal Screening for Prediction of Referral and Outcome Yellow-Flags (OSPRO-YF) original questionnaire (English).

Two native English speakers, knowledge of Spanish, reverse-translate the text to Spanish.

25 participants with musculoskeletal pain completed the Optimal Screening for Prediction of Referral and Outcome (OSPRO) questionnaires.

This outcome will be evaluated according the Consensus-based Standards for the selections of health Measurement Instruments (COSMIN) Risk of Bias checklist for PROMs, using their scoring manual: very good/adequate/doubtful/inadequate/NA for each standar.

from September 2018 to July 2021

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
OSPRO questionnaires Psychometric property Validation
Time Frame: from January to June 2024

The validity and reliability of the Spanish version translated from the questionnaires Optimal Screening for Prediction of Referral and Outcome (OSPRO) will be assessed.

This outcome will be evaluated according the Consensus-based Standards for the selections of health Measurement Instruments (COSMIN) Risk of Bias checklist for PROMs, using their scoring manual: very good/adequate/doubtful/inadequate/NA for each standar.

from January to June 2024

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: ENRIQUE LLUCH GIRBÉS, Universitat de Valencia

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 30, 2020

Primary Completion (Anticipated)

December 31, 2023

Study Completion (Anticipated)

June 30, 2024

Study Registration Dates

First Submitted

May 5, 2023

First Submitted That Met QC Criteria

May 16, 2023

First Posted (Actual)

May 22, 2023

Study Record Updates

Last Update Posted (Actual)

May 22, 2023

Last Update Submitted That Met QC Criteria

May 16, 2023

Last Verified

May 1, 2023

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Musculoskeletal Pain

Clinical Trials on OSPRO-ROS Questionnaire

3
Subscribe